PT  - JOURNAL ARTICLE
AU  - Sichona, Arlon S
AU  - Kyaruzi, Victor Meza
AU  - Joseph, Alex
AU  - Mavura, Maurice P
AU  - Khamis, Ramadhani H
TI  - Factors Associated with Arteriovenous Fistula Maturation Failure among Patients Undergoing Hemodialysis in Hospitals Based in a Low and Middle-Income Country
AID  - 10.1101/2023.04.14.23288585
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.04.14.23288585
4099  - http://medrxiv.org/content/early/2023/04/17/2023.04.14.23288585.short
4100  - http://medrxiv.org/content/early/2023/04/17/2023.04.14.23288585.full
AB  - Introduction The demand for haemodialysis among patients with end stage renal disease (ESRD) is rising worldwide, arteriovenous fistulas (AVF) are considered the gold standard vascular access modality for hemodialysis (HD) because of its longer patency, enhanced durability, and reduced risk of infection for those that mature compared to grafts and central venous catheters. This study will therefore assess the factors associated with arteriovenous fistula maturation for patients requiring hemodialysis in Dar es Salaam.Methods A multi-centre based prospective study conducted among patients with ESRD between April 2021 to May 2022 at Muhimbili National Hospital (MNH), Jakaya Kikwete Cardiac Institute (JKCI), Comprehensive Community Based Rehabilitation in Tanzania (CCBRT),Kairuki hospital (KH) in Dar es Salaam. Patients with End stage renal disease eligible for arteriovenous fistula (AVF) creation and Hemodialysis were included. Socio-demographic data were extracted from the patients, intraoperative and postoperative variables were obtained from medical records. Patients were assessed through eight weeks for maturation and complications. Data analyzed accordingly by IBM-SPSS version 27.0, Univariate and multivariate analysis were used to stratify the factors and control the confounders for the effects on outcome, and p-value of <5% was used to state the level of significance at 95% CI.Results Total of 151 fistulas were created, most (80.8%) were created on male, (31.8%) in the age group of less than 50 Years old, 58.9% of the participants had normal Body Mass Index (BMI), with majority (45%) being suffered from Hypertension and 54% of them were using Antihypertensive medication. Brachial cephalic fistulas were the most common type of fistula created 77(51%) and most matured 67(52.7%) among ESRD patients who had AVF creation, while radial cephalic fistulas were the most failed created AVFs 13 (54%). The AVF maturation failure rate was 16%.Conculusion Failure of newly created AVF is a major barrier to the successful establishment of hemodialysis access, in this study the failure rate of AVF maturation was 16 percent. The major factors associated with failure to mature were; extreme age group (50-59), being suffered with both hypertension and diabetes, long period of alcohol taking and distal location of AVF(radiocephalic fistula).Vascular imaging was not regularly done to assess the status of veins and arteries for AVF creation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical Clearance was approved by Muhimbili University of Health and Allied Sciences IRB REF DA.282/298/01.CI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors